These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 19085967

  • 1. Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
    Ingiliz P, Valantin MA, Duvivier C, Medja F, Dominguez S, Charlotte F, Tubiana R, Poynard T, Katlama C, Lombès A, Benhamou Y.
    Hepatology; 2009 Feb; 49(2):436-42. PubMed ID: 19085967
    [Abstract] [Full Text] [Related]

  • 2. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
    Kovari H, Ledergerber B, Battegay M, Rauch A, Hirschel B, Foguena AK, Vernazza P, Bernasconi E, Mueller NJ, Weber R.
    Clin Infect Dis; 2010 Feb 15; 50(4):502-11. PubMed ID: 20085465
    [Abstract] [Full Text] [Related]

  • 3. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G, Squillace N, Stentarelli C, Orlando G, D'Amico R, Ligabue G, Fiocchi F, Zona S, Loria P, Esposito R, Palella F.
    Clin Infect Dis; 2008 Jul 15; 47(2):250-7. PubMed ID: 18532884
    [Abstract] [Full Text] [Related]

  • 4. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
    Sánchez-Conde M, Berenguer J, Miralles P, Alvarez F, Carlos Lopez J, Cosin J, Pilar C, Ramirez M, Gutierrez I, Alvarez E.
    Clin Infect Dis; 2006 Sep 01; 43(5):640-4. PubMed ID: 16886160
    [Abstract] [Full Text] [Related]

  • 5. [Clinical and histological features of non-alcoholic fatty liver disease].
    Shi JP, Xun YH, Hu CB, Zhang L, Liu H, Lou GQ, Fan JG.
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov 01; 17(11):812-6. PubMed ID: 19958638
    [Abstract] [Full Text] [Related]

  • 6. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
    Sterling RK, Smith PG, Brunt EM.
    J Clin Gastroenterol; 2013 Feb 01; 47(2):182-7. PubMed ID: 23059409
    [Abstract] [Full Text] [Related]

  • 7. [Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads].
    Shi JP, Fan JG, Lou GQ, Zhang L, Hu CB, Wu R, Xun YH.
    Zhonghua Gan Zang Bing Za Zhi; 2008 Nov 01; 16(11):818-22. PubMed ID: 19032864
    [Abstract] [Full Text] [Related]

  • 8. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P.
    Aliment Pharmacol Ther; 2009 Jul 01; 30(1):61-70. PubMed ID: 19292832
    [Abstract] [Full Text] [Related]

  • 9. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
    Martin-Carbonero L, de Ledinghen V, Moreno A, Maida I, Foucher J, Barreiro P, Romero M, Satta G, Garcia-Samaniego J, Gonzalez-Lahoz J, Soriano V.
    J Viral Hepat; 2009 Nov 01; 16(11):790-5. PubMed ID: 19413693
    [Abstract] [Full Text] [Related]

  • 10. The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
    Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS.
    Hepatology; 2005 Jan 01; 41(1):123-31. PubMed ID: 15619237
    [Abstract] [Full Text] [Related]

  • 11. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease.
    Sorbi D, Boynton J, Lindor KD.
    Am J Gastroenterol; 1999 Apr 01; 94(4):1018-22. PubMed ID: 10201476
    [Abstract] [Full Text] [Related]

  • 12. Liver stiffness values in HIV-infected patients with isolated anti-hepatitis B core antibodies.
    Chakvetadze C, Bani-Sadr F, Lescure FX, Fontaine C, Le Pendeven C, Bonnard P, Mariot P, Soussan P, Pialoux G.
    Med Mal Infect; 2013 Jun 01; 43(6):222-5. PubMed ID: 23597924
    [Abstract] [Full Text] [Related]

  • 13. Efavirenz-therapy in HIV-patients with underlying liver disease: importance of continuous TDM of EFV.
    Katsounas A, Frank A, Klinker H, Langmann P.
    Eur J Med Res; 2007 Aug 16; 12(8):331-6. PubMed ID: 17933708
    [Abstract] [Full Text] [Related]

  • 14. Mitochondrial DNA depletion in liver tissue of patients infected with hepatitis C virus: contributing effect of HIV infection?
    Bäuerle J, Laguno M, Mauss S, Mallolas J, Murillas J, Miquel R, Schmutz G, Setzer B, Gatell JM, Walker UA.
    HIV Med; 2005 Mar 16; 6(2):135-9. PubMed ID: 15807720
    [Abstract] [Full Text] [Related]

  • 15. [Differential liver histopathological features of chronic HBV infection patients with normal and mildly elevated serum ALT].
    Ying RS, Yang Z, Chen YY, Yang KL, Xiao YH, Wu LJ, Fan HM.
    Zhonghua Gan Zang Bing Za Zhi; 2012 Aug 16; 20(8):585-8. PubMed ID: 23207151
    [Abstract] [Full Text] [Related]

  • 16. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies.
    Zuckerman E, Zuckerman T, Douer D, Qian D, Levine AM.
    Cancer; 1998 Sep 15; 83(6):1224-30. PubMed ID: 9740089
    [Abstract] [Full Text] [Related]

  • 17. Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis.
    Gatti F, Nasta P, Loregian A, Puoti M, Matti A, Pagni S, de Requena DG, Prestini K, Parisi SG, Bonora S, Palù G, Carosi G.
    J Antimicrob Chemother; 2009 Mar 15; 63(3):575-8. PubMed ID: 19151039
    [Abstract] [Full Text] [Related]

  • 18. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J, Ryzlová M, Striteský J, Horák J.
    Vnitr Lek; 2002 Oct 15; 48(10):924-8. PubMed ID: 16737138
    [Abstract] [Full Text] [Related]

  • 19. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
    Bonnard P, Lescure FX, Amiel C, Guiard-Schmid JB, Callard P, Gharakhanian S, Pialoux G.
    J Viral Hepat; 2007 Nov 15; 14(11):806-11. PubMed ID: 17927617
    [Abstract] [Full Text] [Related]

  • 20. Liver toxicity associated with antiretroviral therapy including efavirenz or ritonavir-boosted protease inhibitors in a cohort of HIV/hepatitis C virus co-infected patients.
    Neukam K, Mira JA, Ruiz-Morales J, Rivero A, Collado A, Torres-Cornejo A, Merino D, de Los Santos-Gil I, Macías J, González-Serrano M, Camacho A, Parra-García G, Pineda JA, SEGURIDAD HEPÁTICA Study Team of the Grupo HEPAVIR de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI).
    J Antimicrob Chemother; 2011 Nov 15; 66(11):2605-14. PubMed ID: 21903660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.